|

Relugolix Combination Tablet Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MVT-601, MVT-601A, MYFEMBREE, RVT-601, T-1331285 +1 more

Pipeline

Phase 3: 1

Top Sponsors

  • Sumitomo Pharma Switzerland GmbH1

Indications

  • Uterine Fibroids1
  • Endometriosis1
  • Cancer1

Mobile, Alabama1 trial

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Mobile

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.